Webinar: End-to-end patient specific QA with RadCalc – why it is important to stay up to date

Join the audience for a live webinar at 7 p.m. BST/2 p.m. EDT on 21 April 2022 exploring the new features in the latest version of RadCalc 7.2.2


In this webinar, we will be covering the new features released in the latest version of RadCalc (7.2.2). These include new workflow features for intelligent automation with Eclipse Scripting and RadCalcAIR that delivers your report in Aria with a single click of the script within the Eclipse TPS. We will also be introducing LAP Academy.

Learn how you can evaluate the treatment performance of your patient’s full course of treatment automatically with the implementation of our Treatment Performance Profiles. This TPP provides a single click method for computing your EPID dosimetry plan dose. We will also give a sneak preview on what we are working on for the next release.

Also, we would like to address a valuable topic: the importance of reviewing change logs and upgrading as new versions are released to ensure the highest safety and quality in the intended patient plans. We will discuss a recent example and our ability to quickly fix our unique plan comparison tool.

The presenter
Carlos Bohorquez, M.S., D.A.B.R is the Product Manager for RadCalc at LifeLine Software, Inc., a part of the LAP Group. An experienced board-certified Clinical Physicist with a proven history of working in the clinic and medical device industry, Carlos’ passion for clinical quality assurance is demonstrated in the research and development of RadCalc into the future. 

Dates and times
To respect our partners and customers worldwide, the webinar will be held in English.

Date: 21 April 2022
Time: 7 p.m. BST/2 p.m. EDT

Register now!

The duration of the webinar will be about 60 minutes including time for Q&A. Unable to attend the live webinar? Please register anyway. The webinar will be recorded and available to view at your convenience.

Never miss any updates - follow us on LinkedIn

Go to top Contact us!